Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3202459 Title: ANTAGONISTES D'ACTRIIB ET DOSAGE ET UTILISATIONS DE CEUX-CI POUR TRAITER L'OBÉSITÉ OU LE DIABÈTE EN RÉGULANT LE TAUX DE GRAISSE CORPORELLE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
161953799
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3202459
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
09/09/2010
Grant date:
14/04/2021
EP publication date:
09/08/2017
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
14/04/2021
EP B1 publication date:
14/04/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
30/09/2021
Expiration date (if granted and all annual fees paid):
09/09/2030

Applicant

Name:
Acceleron Pharma Inc.
Legal Form:
From:
14/04/2021
Address:
128 Sidney Street, Cambridge, MA 02139, United States (US)
To:

Inventor

1

Name:
SEEHRA, Jasbir
Legal Form:
Address:
Lexington, MA Massachusetts 02421-6818, United States (US)

2

Name:
KNOPF, John
Legal Form:
Address:
Carlisle, MA Massachusetts 01741, United States (US)

3

Name:
ATTIE, Ken
Legal Form:
Address:
Boston, MA Massachusetts 02116, United States (US)

Priority

Priority patent number:
276287 P
Priority date:
09/09/2009
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/663; A61K 38/17; A61P 3/04; C07K 14/705;

Publication

Bulletin

Bulletin heading:
VRV
Journal edition number:
2022/09
Publication date:
20/05/2022
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

1

Issue number:
202115
Publication date:
14/04/2021
Description:
Grant (B1)

2

Issue number:
202120
Publication date:
19/05/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type